Search

everythinglearnresearchcommunity

for

Search:↓

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

Synthetic 19-norprogestins promote bone cell growth and function through their non-phenolic metabolites.

Finasteride blocks progesterone's effect on absence seizures in rats.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

Reducing 5α-reductase activity helps endometrial cells differentiate, aiding pregnancy.

Dutasteride may protect the brain in early Parkinson's disease.

Neuroimaging suggests that treatments targeting brain steroids could help control epilepsy, especially types linked to the menstrual cycle.

Rodent models of PCOS show some hormone changes similar to humans, but also have key differences.

Finasteride may affect male fertility by interfering with specific sperm signaling.

Progesterone byproduct 5αP stimulates mammary tumor growth, but finasteride can suppress it.

Finasteride blocks progesterone production in specific tumor cells, potentially causing side effects.

Young girls whose mothers have PCOS may have higher activity of a specific enzyme that could lead to developing PCOS later.

Finasteride reduces testosterone conversion, progesterone lessens this, and levamisole enhances finasteride's effect.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Normal levels of DHT can reduce belly fat and increase muscle, but too much can lead to hair loss, prostate issues, and possibly heart disease.

Progesterone initially worsens but later reduces neuropathic pain in mice, through different mechanisms.

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.

The structure of SRD5A reveals how it reduces steroids, aiding drug design for related health conditions.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

Spironolactone can cause side effects like irregular bleeding, but lower doses may reduce these effects and still improve hirsutism.

New compounds may help treat prostate cancer by reducing cell growth.

Testosterone makes the connections in the uterus lining simpler and lowers certain protein levels, which might lead to infertility.

Progesterone and related compounds may help control seizures linked to the menstrual cycle but have limitations that need addressing.

Progesterone significantly reduces neuroblastoma tumor growth without harming healthy cells.

Neurosteroids can influence behavior by modulating brain inhibition, with potential for treating psychiatric disorders.

Allopregnanolone increases growth and changes gene activity in human brain cancer cells.

Inhibiting 5α-reductase increases progesterone levels in late pregnant mares.

Ovarian and stress hormones can change GABA A receptors through neurosteroids.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.